Outpost Medicine raises $41 mln

Takeda Pharmaceutical Company Ltd and Frazier Healthcare Partners have formed Outpost Medicine, which just completed a $41 million financing led by Frazier Healthcare. Other investors include Adams Street Partners, Novo A/S, and Vivo Capital. Outpost Medicine is developing treatments for urologic and gynecologic diseases and disorders.

North AmericaUSBriefs